Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated 8th February, 2019, please find enclosed herewith the Annual Secretarial Compliance Report issued by M/s. Samdani Shah & Kabra, Practicing Company Secretaries, for the financial year ended 31st March, 2020. We request you to kindly take the same on record.
29-05-2020
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Updated Contact Details Of Key Managerial Personnel / Senior Officials Pursuant To Regulation 30(5) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 With reference to the captioned matter, please find attached the updated contact details of persons authorised for the purpose of determining materiality of an event or information and for making disclosures to the Stock Exchange, pursuant to Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015. We request you to kindly take the same on record.
22-05-2020

Alembic Pharma Q4 profit jumps 81% to Rs 225 crore, FY20 net grows 42%

 The company's revenue increased 30.2 percent to Rs 1,207 crore compared to the corresponding period last fiscal.
22-05-2020
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Audited Financial Results For The Quarter And Financial Year Ended 31St March, 2020.

 Please refer attachment for details.
22-05-2020
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Outcome Of Board Meeting

 Please refer attachment for details
22-05-2020
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Outcome Of Board Meeting

 Please refer attachment for details
22-05-2020
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Raising of Funds

 In continuation of our earlier intimation dated 15th May, 2020 regarding Notice of Board Meeting, inter alia to consider and approve Audited Financial Results of the Company, the exchange is hereby informed that the Board will also consider approving the notice of Annual General Meeting which includes considering an enabling resolution for approval by the members of the Company regarding proposal of raising of funds through issue of securities, in accordance with applicable law, as may be required by the Company from time to time. Kindly take the same on record.
21-05-2020

Buy Alembic Pharma ; target of Rs 1100: YES Securities

 YES Securities is bullish on Alembic Pharma has recommended buy rating on the stock with a target price of Rs 1100 in its research report dated May 19, 2020.
20-05-2020
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 With reference to the captioned subject, this is to inform the exchange that the Company's joint venture, Aleor Dermaceuticals Limited, has received US Food and Drug Administration (USFDA) Approval for Clobetasol Propionate Shampoo, 0.05%. Please find enclosed herewith our press release. We request you to kindly take the same on record.
19-05-2020
Bigul

Trading pick of the week: Buy Alembic Pharmaceuticals

 Investors with a medium-term horizon can buy the stock of Alembic Pharmaceuticals at current levels. The stock took support after recording a 52-week
17-05-2020
Next Page
Close

Let's Open Free Demat Account